Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

Colin Hill Biography and Net Worth

Director of PPD

Colin Hill is a leading voice in machine learning in healthcare and precision medicine. He co-founded GNS Healthcare in 2000 and has since served as Chairman & CEO. Colin sits on boards of BioTelemetry, Inc. and PPD, a leading global contract research organization. Colin was a founding member of the Board of Directors of AesRx, (acquired by Baxter in 2014). In 2004, Colin was named to MIT Technology Review’s TR100 list of the top 100 innovators in the world under the age of 35.

What is Colin Hill's net worth?: The estimated net worth of Colin Hill is at least $669,768.48 as of September 21st, 2020. Mr. Hill owns 14,166 shares of PPD stock worth more than $669,768 as of November 23rd. This net worth estimate does not reflect any other investments that Mr. Hill may own. Learn More about Colin Hill's net worth.
How do I contact Colin Hill?: The corporate mailing address for Mr. Hill and other PPD executives is 929 NORTH FRONT STREET, WILMINGTON NC, 28401. PPD can also be reached via phone at 910-251-0081 and via email at [email protected]. Learn More on Colin Hill's contact information.
Has Colin Hill been buying or selling shares of PPD?: Colin Hill has not been actively trading shares of PPD during the last quarter. Most recently, Colin Hill sold 1,722 shares of the business's stock in a transaction on Monday, September 21st. The shares were sold at an average price of $31.28, for a transaction totalling $53,864.16. Following the completion of the sale, the director now directly owns 14,166 shares of the company's stock, valued at $443,112.48. Learn More on Colin Hill's trading history.
Who are PPD's active insiders?: PPD's insider roster includes Glen Donovan (CAO), Ronald Garrow (Insider), Colin Hill (Director), David Johnston (Insider), Karen Kaucic (Insider), and David Simmons (CEO). Learn More on PPD's active insiders.

Colin Hill Insider Trading History at PPD

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/21/2020	Sell	1,722	$31.28	$53,864.16	14,166

Colin Hill Buying and Selling Activity at PPD

PPD Company Overview

PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.

Today's Range

Now: $47.28

$47.28

50 Day Range

MA: $47.27

$47.10

$47.41

2 Week Range

Now: $47.28

$31.54

$47.41

Volume

N/A

Average Volume

1,905,567 shs

Market Capitalization

$16.61 billion

P/E Ratio

47.28

Dividend Yield

N/A

Beta

1.96

Trump won. Buy this coin now.

From Weiss Ratings | Ad